Takeda celebrates 25 years of business in Ireland
Takeda in Ireland, a subsidiary of Takeda headquartered in Tokyo, Japan, has celebrated 25 years of business in Ireland with an anniversary event at its Bray site. Since first establishing this manufacturing facility in 1997, the company has developed three other locations in Ireland – Baggot Street, Citywest and Grange Castle – which collectively employ over 900 people and have been certified as a global and Irish Top Employer for the last five years. The sites provide innovative medicines to patients in more than 60 international markets.
In the last 25 years, the company has gone from strength to strength, and, notably, the Takeda facility in Bray has seen significant growth in its production portfolio, with the addition of a new oncology production suite inaugurated in 2020. The site plans on continuing this growth while meeting ambitious environmental goals that build on the site’s existing use of 100% renewable electricity.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader which focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). It also makes targeted R&D investments in Plasma-Derived Therapies and Vaccines.
